ACUTE MYELOID LEUKAEMIA (AML)
Clinical trials for ACUTE MYELOID LEUKAEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKAEMIA (AML) trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKAEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Researchers test if kidney health changes transplant drug dose for leukemia patients
Disease control Recruiting nowThis study aims to understand how kidney function and race/ethnicity affect how the body processes a drug called treosulfan, which is used to prepare patients for a stem cell transplant. The research involves 36 adults with acute myeloid leukemia or myelodysplastic syndrome who a…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE1 • Sponsor: medac GmbH • Aim: Disease control
Last updated Apr 01, 2026 19:56 UTC
-
New hope for tough leukemia: trial tests promising drug combo
Disease control Recruiting nowThis study is testing whether adding a new drug called L-Annamycin to a standard chemotherapy (cytarabine) works better than the standard chemo alone for adults with acute myeloid leukemia (AML) that has come back or didn't respond to first treatment. The goal is to put the cance…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE2, PHASE3 • Sponsor: Moleculin Biotech, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug combo aims to keep deadly blood cancer at bay
Disease control Recruiting nowThis study is testing whether a two-drug maintenance therapy can help keep acute myeloid leukemia (AML) from returning in fit patients who have achieved remission after strong chemotherapy. It is for patients aged 18-60 who are either waiting for a bone marrow transplant or canno…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: NA • Sponsor: Sohag University • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
New Triple-Threat attack on hidden leukemia cells aims to stop relapse
Disease control Recruiting nowThis study is testing whether a new combination of three drugs can safely control hidden leukemia cells and prevent the cancer from coming back in adults with acute myeloid leukemia (AML). The goal is to see if adding a new drug called tagraxofusp to two standard drugs helps elim…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE1, PHASE2 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
Scientists hunt for hidden clues in blood cancer patients
Knowledge-focused Recruiting nowThis study aims to discover molecular patterns in blood and tissue that might predict how patients with acute myeloid leukemia or follicular lymphoma respond to treatment. Researchers will collect samples from 550 patients during their regular care and track their health outcomes…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Sponsor: Tempus AI • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC